CAPECCHI, PIER LEOPOLDO
 Distribuzione geografica
Continente #
NA - Nord America 12.335
EU - Europa 10.096
AS - Asia 4.694
SA - Sud America 901
AF - Africa 130
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 28.182
Nazione #
US - Stati Uniti d'America 12.191
GB - Regno Unito 2.435
RU - Federazione Russa 2.010
CN - Cina 1.850
SG - Singapore 1.447
IE - Irlanda 1.314
IT - Italia 1.106
SE - Svezia 793
BR - Brasile 785
DE - Germania 713
UA - Ucraina 689
FR - Francia 421
HK - Hong Kong 397
FI - Finlandia 286
VN - Vietnam 271
KR - Corea 261
IN - India 140
CA - Canada 83
ES - Italia 68
TR - Turchia 59
NL - Olanda 50
CI - Costa d'Avorio 44
AR - Argentina 40
MX - Messico 40
BE - Belgio 36
PL - Polonia 36
BD - Bangladesh 35
JP - Giappone 32
ZA - Sudafrica 31
AT - Austria 28
CZ - Repubblica Ceca 28
PK - Pakistan 28
IQ - Iraq 23
EC - Ecuador 22
TH - Thailandia 21
VE - Venezuela 18
IR - Iran 15
AU - Australia 14
MA - Marocco 13
LT - Lituania 12
AZ - Azerbaigian 11
AE - Emirati Arabi Uniti 10
IL - Israele 10
KZ - Kazakistan 10
SA - Arabia Saudita 10
GR - Grecia 9
TN - Tunisia 9
EG - Egitto 8
JO - Giordania 8
CH - Svizzera 7
EU - Europa 7
NP - Nepal 7
PE - Perù 7
PY - Paraguay 7
UZ - Uzbekistan 7
BO - Bolivia 6
CO - Colombia 6
DZ - Algeria 6
ID - Indonesia 6
JM - Giamaica 6
BG - Bulgaria 5
ET - Etiopia 5
KE - Kenya 5
LV - Lettonia 5
OM - Oman 5
RO - Romania 5
RS - Serbia 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
HR - Croazia 4
KG - Kirghizistan 4
NG - Nigeria 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
CL - Cile 3
DO - Repubblica Dominicana 3
MK - Macedonia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PA - Panama 3
AM - Armenia 2
BB - Barbados 2
BY - Bielorussia 2
DK - Danimarca 2
EE - Estonia 2
HN - Honduras 2
HU - Ungheria 2
IM - Isola di Man 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
PS - Palestinian Territory 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CY - Cipro 1
FK - Isole Falkland (Malvinas) 1
Totale 28.160
Città #
Southend 2.190
Dallas 1.584
Fairfield 1.433
Dublin 1.289
Ashburn 973
Singapore 833
Chandler 691
Woodbridge 673
Moscow 561
Jacksonville 549
Houston 546
Santa Clara 543
Wilmington 536
Seattle 518
Beijing 491
Cambridge 463
Siena 397
Hong Kong 394
Ann Arbor 363
Menlo Park 358
Hefei 277
Seoul 259
Princeton 242
Nanjing 201
New York 154
Munich 147
Los Angeles 136
Dong Ket 135
The Dalles 119
Helsinki 113
Dearborn 108
Boardman 106
Milan 99
San Diego 93
San Mateo 88
Buffalo 82
São Paulo 80
Nanchang 74
Florence 71
Shanghai 58
Turku 57
Council Bluffs 55
Shenyang 54
Columbus 50
Ho Chi Minh City 48
Abidjan 44
Düsseldorf 43
Brooklyn 42
Bengaluru 40
Málaga 39
San Francisco 37
Brussels 36
London 35
Nuremberg 34
Toronto 34
Changsha 33
Chicago 33
Redondo Beach 33
Tianjin 32
Hebei 31
Guangzhou 30
Rome 30
Hanoi 29
Poggiomarino 29
Izmir 27
Kunming 27
Phoenix 27
Tokyo 26
Warsaw 26
Jiaxing 25
Jinan 24
Johannesburg 24
Lancaster 24
Norwalk 23
Lappeenranta 22
Poplar 22
Rio de Janeiro 22
Falls Church 21
Denver 20
Montreal 20
Atlanta 19
Ankara 18
Chennai 18
Orem 18
Zhengzhou 18
Boston 17
Washington 17
Stockholm 16
Belo Horizonte 15
Fremont 15
Frankfurt am Main 14
Mumbai 14
Pune 14
Venezia 14
Brno 13
Olomouc 13
Amsterdam 12
Hangzhou 12
Manchester 12
Baku 11
Totale 19.635
Nome #
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 372
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 369
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 369
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 363
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 343
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 338
Antirheumatic agents in covid-19: is IL-6 the right target? 332
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 326
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 317
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 311
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 299
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 298
Peripheral biomarkers' panel for severe COVID-19 patients 292
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 289
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 288
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 282
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 280
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 275
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 266
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 261
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 258
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 255
Allopurinol prevents ischaemia-dependent haemorheological changes 255
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 239
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 239
Torsades de Pointes in patients with polymyalgia rheumatica 237
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 237
Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies 235
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 229
Pleuroparenchymal fibroelastosis (PPFE) associated with giant cell arteritis: A coincidence or a novel phenotype? 226
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 224
Polyneuropathy with demyelinating changes in Churg–Strauss syndrome: an unusual association 224
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 224
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients 223
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 223
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 223
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 223
The role of P2X7 receptors in tissue fibrosis: a brief review 222
Heart failure and chronic kidney disease in a registry of internal medicine wards 221
Alteration in the redox state of plasma in heart transplanted patients with moderate hyperhomocisteinemia 220
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 218
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 217
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 216
Serial KL-6 measurements in COVID-19 patients 215
Statins and the joint: multiple targets for a global protection? 214
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 213
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 209
Connective tissue diseases and cardiac rhythm disorders: an overview 208
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 208
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 207
Human rheumatoid synoviocytes express functional P2X7 receptors 207
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 206
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 205
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 205
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 204
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 204
Risk factors for hospital readmission of elderly patients 198
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 198
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders 198
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 197
Adenosine A2(A) receptor gene polymorphism (1976C > T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy 192
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 192
Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofloxacin in humans 187
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 187
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 186
Ultrasound measurement of rectus femoris muscle thickness as a quick screening test for sarcopenia assessment 186
Pathogenesis of the novel autoimmune-associated long-QT syndrome 181
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 181
Using peripheral blood mononuclear cells to determine proteome profiles in human cardiac failure 180
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 179
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 177
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 176
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 174
Familial Mediterranean fever diagnosed in an elderly patient 173
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 173
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 171
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 169
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 169
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 168
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 165
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 164
ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family 163
Enhanced apoptosis of peripheral blood mononuclear cells (PBMC) in cardiac transplanted patients undergoing chronic immunosuppressive treatment 163
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 162
Photopheresis immunomodulation after heart transplantation. 162
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 162
Homocysteine and Raynaud’s phenomenon: a review 162
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 159
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 159
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 158
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 158
Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b 157
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 157
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 155
Comment on: Letter to the Editor from Clockaerts and Bierma-Zeinstra 154
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 154
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 154
Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly 153
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy 152
Blunted increase in plasma adenosine levels following dipyridamole stress test in dilated cardiomyopathy patients 152
Totale 21.780
Categoria #
all - tutte 89.244
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.244


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.038 0 0 0 0 0 340 201 365 321 284 254 273
2021/20222.192 159 283 133 169 159 74 130 96 138 195 220 436
2022/20232.560 161 250 366 373 204 501 74 187 265 55 68 56
2023/20242.219 93 48 176 111 110 613 686 54 26 62 61 179
2024/20254.344 85 216 392 266 520 257 183 264 315 217 500 1.129
2025/20266.742 866 1.494 1.051 1.139 1.923 269 0 0 0 0 0 0
Totale 28.570